These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 16200462)

  • 1. Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.
    Reddy S; Pathipati P; Bai Y; Robinson E; Ross JM
    J Mol Histol; 2005 May; 36(4):289-300. PubMed ID: 16200462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
    Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
    Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
    Reddy S; Yip S; Karanam M; Poole CA; Ross JM
    Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
    Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.
    Reddy S; Young M; Ginn S
    Histochem J; 2001 Jun; 33(6):317-27. PubMed ID: 11758808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study.
    Reddy S; Chai RC; Rodrigues JA; Hsu TH; Robinson E
    J Mol Histol; 2008 Feb; 39(1):25-36. PubMed ID: 17891462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
    Plesner A; Ten Holder JT; Verchere CB
    PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes.
    Bai Y; Robinson E; Chai R; Ross JM; Reddy S
    J Mol Histol; 2006 May; 37(3-4):101-13. PubMed ID: 17063385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S; Bai Y; Robinson E; Ross J
    Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical demonstration of leptin in pancreatic islets of non-obese diabetic and CD-1 mice: co-localization in glucagon cells and its attenuation at the onset of diabetes.
    Reddy S; Lau EM; Ross JM
    J Mol Histol; 2004 Jun; 35(5):511-9. PubMed ID: 15571328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of nitrotyrosine, a biomarker of oxidative stress, in islet cells of the NOD mouse.
    Reddy S; Bradley J
    Ann N Y Acad Sci; 2004 Dec; 1037():199-202. PubMed ID: 15699517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes.
    Coutinho-Silva R; Robson T; Beales PE; Burnstock G
    Autoimmunity; 2007 Mar; 40(2):108-16. PubMed ID: 17364502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
    Augstein P; Elefanty AG; Allison J; Harrison LC
    Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Reddy S; Ross JM
    Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
    Tomita T
    Islets; 2011; 3(4):166-74. PubMed ID: 21633185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.